Integration and collaboration are sometimes overlooked but are crucial for the success of bioprocess projects.

AI’s predictive capabilities are increasing and perhaps surpassing human intuition in predicting the outcomes of neuroscience ...

The CRISPR-SCD trial is the first clinical attempt to use a non-viral delivery approach to directly correct the sickle cell ...

GEN has put together a list of some great science-related gifts for this holiday season, from books to hoodies to jewelry.

Preclinical studies showed that the addition of IL-15 could improve the performance of CAR T cell-based immunotherapies.

Novartis will partner with PTC Therapeutics to develop PTC’s PTC518 Huntington's disease program and an unspecified number of related molecules, through an up-to-$2.9 billion exclusive global license ...

Antibiotic resistance study explores a recently identified mechanism in bacteria: the shedding of methylation marks from ribosomal RNA.

Researchers hope findings will lead to new class of drugs for many different diseases for which proteolethargy is a common ...

Studying patients with PD-1 or PD-L1 deficiency may help inform new approaches to fine-tuning immunotherapies to maximise ...

Attruby (acoramidis), a near complete TTR stabilizer, has been approved by FDA to reduce cardiovascular death and ...

Researchers suggest broadly reactive antibodies identified are likely to represent a common mechanism of acquired immunity to ...

GEN highlights six AI-based drug discoverers worthy of note based on pipeline or platform progress, and in one instance, a ...